Clinical Trials
12 trialsNCT07021495 2025-08-19
SKINERGY
Leiden University Medical Center
Recruiting
NCT06931119 2025-04-17
Aprepitant in the Management of Immune Checkpoint Inhibitors Pruritus in Solid Cancer Patients
Rabin Medical Center
Phase 1 Not yet recruiting
NCT03992664 2025-02-13
Education Intervention in Patients with Rash Due to Epidermal Growth Factor Receptor (EGFR) Treatment.
Cyprus University of Technology
Phase NA Completed
NCT06688643 2024-11-14
The Impact of Intrathecal Morphine Versus Continuous Epidural Analgesia on Return of Bowel Function in Patients Undergoing Laparoscopic Ileal Conduit
Inner Mongolia Baogang Hospital
Phase NA Completed
NCT04018209 2024-11-01
PANAM
University Hospital, Brest
Completed
NCT03673878 2022-01-27
PRURI-C
University Hospital, Brest
Completed
NCT02646020 2021-05-18
EGFR-TKIs
Sun Yat-sen University
Phase 2 Completed
NCT03340155 2017-11-13
BioUV2017
Medical University of Graz
Phase NA Unknown
NCT03290989 2017-09-25
PRURITCC
University Hospital, Brest
Completed
NCT01625455 2017-05-10
Effect of Neurokinin-1 Receptor (NK1R) Antagonism on Pruritus in Patients With Sezary Syndrome
Vanderbilt University Medical Center
Phase 4 Terminated
NCT01801670 2015-01-27
Impact of Vorinostat on Pruritus Signaling Pathways - Merck Study
Boston University
Withdrawn
NCT00863395 2014-03-31
CTCL
University of Minnesota
Phase 1/2 Terminated